{"transactions":[{"id":947572,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T16:26:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514826000071/form4.xml","form_type":"4"}},{"id":947571,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T16:26:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":7484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":7484,"derivative":{"underlying":"Common Stock","underlying_shares":7484},"source":{"system":"sec-edgar","filing":"0000905148-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514826000071/form4.xml","form_type":"4"}},{"id":1096007,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-07-02T16:32:13.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":false,"shares":26368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These fully vested RSUs settled on July 1, 2025, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These fully vested RSUs settled on July 1, 2025, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26368},"source":{"system":"sec-edgar","filing":"0000905148-25-002316","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514825002316/form4.xml","form_type":"4"}},{"id":1096006,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-02T16:32:13.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":true,"shares":26368,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":310135,"source":{"system":"sec-edgar","filing":"0000905148-25-002316","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514825002316/form4.xml","form_type":"4"}},{"id":1137691,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-22T16:16:13.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":42010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":42010,"derivative":{"exercise_price":0.2708,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":42010},"source":{"system":"sec-edgar","filing":"0000905148-25-001895","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514825001895/form4.xml","form_type":"4"}},{"id":1137690,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-22T16:16:13.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":86477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":86477,"derivative":{"underlying":"Common Stock","underlying_shares":86477},"source":{"system":"sec-edgar","filing":"0000905148-25-001895","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514825001895/form4.xml","form_type":"4"}},{"id":1374414,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-06T15:15:55.000Z","date":"2024-11-05","kind":"purchase","planned":false,"acquired":true,"shares":22500,"price":1.3718,"value":30865.5,"ownership":{"direct":false,"nature":"By Massarany Family Trust dated November 15, 2012"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.355 to $1.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":53364,"source":{"system":"sec-edgar","filing":"0000905148-24-002947","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514824002947/form4.xml","form_type":"4"}},{"id":1466761,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-07-01T18:32:02.000Z","date":"2024-06-28","kind":"exercise","planned":false,"acquired":false,"shares":4737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024."}],"balance_after":18947,"derivative":{"underlying":"Common Stock","underlying_shares":4737},"source":{"system":"sec-edgar","filing":"0001104659-24-076961","document":"tm2418614-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924076961/tm2418614-3_4seq1.xml","form_type":"4"}},{"id":1466760,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T18:32:02.000Z","date":"2024-06-28","kind":"exercise","planned":false,"acquired":true,"shares":4737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."}],"balance_after":36891,"source":{"system":"sec-edgar","filing":"0001104659-24-076961","document":"tm2418614-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924076961/tm2418614-3_4seq1.xml","form_type":"4"}},{"id":1498611,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-30T16:16:16.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":7894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 29, 2023, the reporting person was granted a total of 7,894 RSUs, which vested on the first-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 29, 2023, the reporting person was granted a total of 7,894 RSUs, which vested on the first-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7894},"source":{"system":"sec-edgar","filing":"0001104659-24-066659","document":"tm2415918-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924066659/tm2415918-2_4seq1.xml","form_type":"4"}},{"id":1498610,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T16:16:16.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":7894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."}],"balance_after":32154,"source":{"system":"sec-edgar","filing":"0001104659-24-066659","document":"tm2415918-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924066659/tm2415918-2_4seq1.xml","form_type":"4"}},{"id":1504032,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-23T19:14:18.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":37050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37050,"derivative":{"exercise_price":1.57,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":37050},"source":{"system":"sec-edgar","filing":"0000905148-24-001611","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514824001611/form4.xml","form_type":"4"}},{"id":1504031,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-23T19:14:18.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":57246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":57246,"derivative":{"underlying":"Common Stock","underlying_shares":57246},"source":{"system":"sec-edgar","filing":"0000905148-24-001611","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514824001611/form4.xml","form_type":"4"}},{"id":1508167,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-21T18:57:28.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served."}],"balance_after":66667,"derivative":{"underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001104659-24-063959","document":"tm2415084-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924063959/tm2415084-1_4seq1.xml","form_type":"4"}},{"id":1671552,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-01-25T16:10:59.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,666 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."}],"balance_after":16666,"derivative":{"exercise_price":1.65,"exercise_date":"2024-01-23","expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001104659-24-006672","document":"tm244005-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006672/tm244005-2_4seq1.xml","form_type":"4"}},{"id":1671551,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T16:10:59.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,666 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."}],"balance_after":24260,"source":{"system":"sec-edgar","filing":"0001104659-24-006672","document":"tm244005-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006672/tm244005-2_4seq1.xml","form_type":"4"}},{"id":1693644,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-03T16:16:19.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":105389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":142924,"derivative":{"underlying":"Common Stock","underlying_shares":105389},"source":{"system":"sec-edgar","filing":"0000905148-24-000042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514824000042/form4.xml","form_type":"4"}},{"id":1814033,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T17:31:09.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":30864,"price":1.62,"value":49999.68,"ownership":{"direct":false,"nature":"By Massarany Family Trust dated November 15, 2012"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":30864,"source":{"system":"sec-edgar","filing":"0000905148-23-000624","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514823000624/form4.xml","form_type":"4"}},{"id":1842392,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-29T18:03:03.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":236842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 28, 2023, the reporting person was granted RSUs which vest in equal amounts each year for 5 years, with the first installment vesting on June 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":236842,"derivative":{"underlying":"Common Stock","underlying_shares":236842},"source":{"system":"sec-edgar","filing":"0001628280-23-023941","document":"wk-form4_1688076170.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023023941/wk-form4_1688076170.xml","form_type":"4"}},{"id":1872802,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-01T20:30:11.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":75949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":75949},"source":{"system":"sec-edgar","filing":"0001628280-23-020597","document":"wk-form4_1685665801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023020597/wk-form4_1685665801.xml","form_type":"4"}},{"id":1872801,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T20:30:11.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":75949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023."}],"balance_after":75949,"source":{"system":"sec-edgar","filing":"0001628280-23-020597","document":"wk-form4_1685665801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023020597/wk-form4_1685665801.xml","form_type":"4"}},{"id":1872794,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-01T18:29:01.000Z","date":"2023-05-29","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 29, 2023, the reporting person was granted RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":78947,"derivative":{"underlying":"Common Stock","underlying_shares":78947},"source":{"system":"sec-edgar","filing":"0001628280-23-020568","document":"wk-form4_1685658532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023020568/wk-form4_1685658532.xml","form_type":"4"}},{"id":1878467,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-25T18:21:29.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":37535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37535,"derivative":{"underlying":"Common Stock","underlying_shares":37535},"source":{"system":"sec-edgar","filing":"0001140361-23-026714","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000114036123026714/form4.xml","form_type":"4"}},{"id":1929328,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-04T16:39:26.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":145833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vested in full on March 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vested in full on March 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 6,707 deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":6707,"derivative":{"underlying":"Common Stock","underlying_shares":145833},"source":{"system":"sec-edgar","filing":"0001140361-23-016265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000114036123016265/form4.xml","form_type":"4"}},{"id":1929327,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-04T16:39:26.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":145833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":283767,"source":{"system":"sec-edgar","filing":"0001140361-23-016265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000114036123016265/form4.xml","form_type":"4"}},{"id":2063279,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-05T16:31:10.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":6707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 6,707 deferred RSUs.  The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":152540,"derivative":{"underlying":"Common Stock","underlying_shares":6707},"source":{"system":"sec-edgar","filing":"0001140361-23-000669","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000114036123000669/form4.xml","form_type":"4"}},{"id":2068950,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-04T18:20:31.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":145833,"derivative":{"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001140361-23-000518","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000114036123000518/form4.xml","form_type":"4"}},{"id":2108920,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T18:03:20.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":130434,"price":1.15,"value":149999.1,"ownership":{"direct":true},"balance_after":137934,"source":{"system":"sec-edgar","filing":"0001140361-22-042604","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000114036122042604/form4.xml","form_type":"4"}},{"id":2248648,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2022-06-02T16:20:48.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":75949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on May 31, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":75949,"derivative":{"underlying":"Common Stock","underlying_shares":75949},"source":{"system":"sec-edgar","filing":"0001628280-22-016059","document":"wf-form4_165420122522746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828022016059/wf-form4_165420122522746.xml","form_type":"4"}},{"id":2255515,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-26T16:15:57.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."}],"balance_after":83333,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001140361-22-020787","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000114036122020787/form4.xml","form_type":"4"}},{"id":2420388,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T18:05:58.000Z","date":"2022-01-31","kind":"purchase","acquired":true,"shares":20000,"price":3.3,"value":66000.0,"ownership":{"direct":false,"nature":"Massarany Family Trust dated November 15, 2012"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.18 to $3.35, inclusive. The reporting person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001628280-22-001586","document":"wf-form4_164375674159436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828022001586/wf-form4_164375674159436.xml","form_type":"4"}},{"id":2558336,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-28T15:46:26.000Z","date":"2021-09-27","kind":"purchase","acquired":true,"shares":10000,"price":5.3,"value":53000.0,"ownership":{"direct":false,"nature":"Massarany Family Trust dated November 15, 2012"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.29 to $5.32, inclusive. The reporting person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001628280-21-019223","document":"wf-form4_163285836756524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828021019223/wf-form4_163285836756524.xml","form_type":"4"}},{"id":2648198,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true}}],"security":"Stock Options (Right to buy)","published_at":"2021-07-01T18:23:10.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":25789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on March 31, 2022."}],"balance_after":25789,"derivative":{"exercise_price":13.72,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":25789},"source":{"system":"sec-edgar","filing":"0000905148-21-000538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000090514821000538/form4.xml","form_type":"4"}},{"id":2699992,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T21:59:45.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":31261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on May 20, 2022."}],"balance_after":31261,"derivative":{"exercise_price":7.68,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":31261},"source":{"system":"sec-edgar","filing":"0001104659-21-071494","document":"tm2117458d3_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465921071494/tm2117458d3_form4.xml","form_type":"4"}},{"id":2699991,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T21:59:45.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":93783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in five equal annual installments beginning on May 20, 2022."}],"balance_after":93783,"derivative":{"exercise_price":7.68,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":93783},"source":{"system":"sec-edgar","filing":"0001104659-21-071494","document":"tm2117458d3_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465921071494/tm2117458d3_form4.xml","form_type":"4"}},{"id":2995101,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-11-03T18:22:06.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":26368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer Common Stock (\"Common Stock\"). These RSUs vest 40% on July 1, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from July 1, 2022."}],"balance_after":26368,"derivative":{"exercise_price":6.83,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":26368},"source":{"system":"sec-edgar","filing":"0001209191-20-056745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000120919120056745/doc4.xml","form_type":"4"}},{"id":2995100,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2020-11-03T18:22:06.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":35158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 12 successive, equal monthly installments measured from July 1, 2020."}],"balance_after":35158,"derivative":{"exercise_price":6.83,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":35158},"source":{"system":"sec-edgar","filing":"0001209191-20-056745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000120919120056745/doc4.xml","form_type":"4"}},{"id":2995099,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T18:22:06.000Z","date":"2020-10-30","kind":"purchase","acquired":true,"shares":7500,"price":18,"value":135000.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-20-056745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000120919120056745/doc4.xml","form_type":"4"}},{"id":3304302,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2020-01-23T18:32:12.000Z","date":"2020-01-23","kind":"exercise","acquired":true,"shares":52642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."}],"balance_after":164858,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":52642},"source":{"system":"sec-edgar","filing":"0001487371-20-000010","document":"wf-form4_157982231527226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737120000010/wf-form4_157982231527226.xml","form_type":"4"}},{"id":3304301,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2020-01-23T18:32:12.000Z","date":"2020-01-23","kind":"exercise","acquired":true,"shares":22407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."}],"balance_after":47371,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":22407},"source":{"system":"sec-edgar","filing":"0001487371-20-000010","document":"wf-form4_157982231527226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737120000010/wf-form4_157982231527226.xml","form_type":"4"}},{"id":3304300,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-23T18:32:12.000Z","date":"2020-01-23","kind":"sale","acquired":false,"shares":28920,"price":4.9,"value":141708.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $4.80 to $5.12 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":822174,"source":{"system":"sec-edgar","filing":"0001487371-20-000010","document":"wf-form4_157982231527226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737120000010/wf-form4_157982231527226.xml","form_type":"4"}},{"id":3304299,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-23T18:32:12.000Z","date":"2020-01-23","kind":"exercise","acquired":true,"shares":75049,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":851094,"source":{"system":"sec-edgar","filing":"0001487371-20-000010","document":"wf-form4_157982231527226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737120000010/wf-form4_157982231527226.xml","form_type":"4"}},{"id":3358966,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-26T17:02:39.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":16423,"price":5.43,"value":89176.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":776045,"source":{"system":"sec-edgar","filing":"0001487371-19-000267","document":"wf-form4_157480573998340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000267/wf-form4_157480573998340.xml","form_type":"4"}},{"id":3363239,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-21T16:54:53.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":7744,"price":5.55,"value":42979.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":792468,"source":{"system":"sec-edgar","filing":"0001487371-19-000249","document":"wf-form4_157437327699383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000249/wf-form4_157437327699383.xml","form_type":"4"}},{"id":3426048,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-30T19:02:38.000Z","date":"2019-08-27","kind":"sale","acquired":false,"shares":16659,"price":6.03,"value":100453.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":800212,"source":{"system":"sec-edgar","filing":"0001487371-19-000218","document":"wf-form4_156720614076127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000218/wf-form4_156720614076127.xml","form_type":"4"}},{"id":3432249,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-21T17:02:04.000Z","date":"2019-08-20","kind":"sale","acquired":false,"shares":8080,"price":6.25,"value":50500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":816871,"source":{"system":"sec-edgar","filing":"0001487371-19-000198","document":"wf-form4_156642130781714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000198/wf-form4_156642130781714.xml","form_type":"4"}},{"id":3506512,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-31T16:24:52.000Z","date":"2019-05-30","kind":"sale","acquired":false,"shares":10369,"price":6.6,"value":68435.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":824951,"source":{"system":"sec-edgar","filing":"0001487371-19-000143","document":"wf-form4_155933427829479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000143/wf-form4_155933427829479.xml","form_type":"4"}},{"id":3510443,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-28T16:34:59.000Z","date":"2019-05-24","kind":"sale","acquired":false,"shares":6247,"price":6.62,"value":41355.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":835320,"source":{"system":"sec-edgar","filing":"0001487371-19-000137","document":"wf-form4_155907568278010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000137/wf-form4_155907568278010.xml","form_type":"4"}},{"id":3515580,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-22T17:05:53.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":7837,"price":6.83,"value":53526.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":841567,"source":{"system":"sec-edgar","filing":"0001487371-19-000119","document":"wf-form4_155855913930592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000119/wf-form4_155855913930592.xml","form_type":"4"}},{"id":3629448,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-27T16:37:17.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":54596,"price":6.79,"value":370706.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.78 to $7.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":849404,"source":{"system":"sec-edgar","filing":"0001487371-19-000070","document":"wf-form4_155130342304464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000070/wf-form4_155130342304464.xml","form_type":"4"}},{"id":3642324,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2019-02-21T19:07:14.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":217500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":217500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":217500},"source":{"system":"sec-edgar","filing":"0001487371-19-000042","document":"wf-form4_155079390848313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000042/wf-form4_155079390848313.xml","form_type":"4"}},{"id":3642323,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-21T19:07:14.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":5562,"price":6.16,"value":34261.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":904000,"source":{"system":"sec-edgar","filing":"0001487371-19-000042","document":"wf-form4_155079390848313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000042/wf-form4_155079390848313.xml","form_type":"4"}},{"id":3642322,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-21T19:07:14.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":217500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 25% on February 18, 2020 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter."}],"balance_after":909562,"source":{"system":"sec-edgar","filing":"0001487371-19-000042","document":"wf-form4_155079390848313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000042/wf-form4_155079390848313.xml","form_type":"4"}},{"id":3686885,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-25T18:25:15.000Z","date":"2019-01-23","kind":"sale","acquired":false,"shares":15166,"price":5.9,"value":89479.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units."}],"balance_after":692062,"source":{"system":"sec-edgar","filing":"0001487371-19-000024","document":"wf-form4_154845869892952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000024/wf-form4_154845869892952.xml","form_type":"4"}},{"id":3690913,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2019-01-22T19:37:20.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":40229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":69771,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":40229},"source":{"system":"sec-edgar","filing":"0001487371-19-000016","document":"wf-form4_154820382398269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000016/wf-form4_154820382398269.xml","form_type":"4"}},{"id":3690912,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-22T19:37:20.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":40229,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":707228,"source":{"system":"sec-edgar","filing":"0001487371-19-000016","document":"wf-form4_154820382398269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737119000016/wf-form4_154820382398269.xml","form_type":"4"}},{"id":3749538,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-29T16:32:33.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":5884,"price":5.08,"value":29890.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":666999,"source":{"system":"sec-edgar","filing":"0001487371-18-000237","document":"wf-form4_154352713703901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000237/wf-form4_154352713703901.xml","form_type":"4"}},{"id":3753023,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-26T16:50:19.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":8047,"price":4.84,"value":38947.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":672883,"source":{"system":"sec-edgar","filing":"0001487371-18-000222","document":"wf-form4_154326900136009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000222/wf-form4_154326900136009.xml","form_type":"4"}},{"id":3773242,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-06T16:53:59.000Z","date":"2018-11-05","kind":"sale","acquired":false,"shares":1561,"price":4.85,"value":7570.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":680930,"source":{"system":"sec-edgar","filing":"0001487371-18-000212","document":"wf-form4_154154122333328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000212/wf-form4_154154122333328.xml","form_type":"4"}},{"id":3832965,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-27T13:10:28.000Z","date":"2018-08-24","kind":"sale","acquired":false,"shares":6203,"price":7.16,"value":44413.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":682491,"source":{"system":"sec-edgar","filing":"0001487371-18-000175","document":"wf-form4_153538981216118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000175/wf-form4_153538981216118.xml","form_type":"4"}},{"id":3836210,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-22T17:37:34.000Z","date":"2018-08-21","kind":"sale","acquired":false,"shares":6010,"price":7.39,"value":44413.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":688694,"source":{"system":"sec-edgar","filing":"0001487371-18-000161","document":"wf-form4_153497383826102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000161/wf-form4_153497383826102.xml","form_type":"4"}},{"id":3852021,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-06T19:25:38.000Z","date":"2018-08-03","kind":"sale","acquired":false,"shares":1004,"price":7.2,"value":7228.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount reported includes 1,500 shares of the Issuer's common stock acquired under the GenMark Diagnostics, Inc. Amended and Restated 2013 Employee Stock Purchase Plan since the reporting person last filed a Form 4 with the Securities Exchange Commission."}],"balance_after":694704,"source":{"system":"sec-edgar","filing":"0001134554-18-000005","document":"wf-form4_153359792297990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000113455418000005/wf-form4_153359792297990.xml","form_type":"4"}},{"id":3918919,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-24T18:47:30.000Z","date":"2018-05-23","kind":"sale","acquired":false,"shares":4168,"price":6.88,"value":28675.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":694208,"source":{"system":"sec-edgar","filing":"0001487371-18-000113","document":"wf-form4_152720198741158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000113/wf-form4_152720198741158.xml","form_type":"4"}},{"id":3922284,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-22T16:56:47.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":5459,"price":6.91,"value":37721.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":698376,"source":{"system":"sec-edgar","filing":"0001487371-18-000108","document":"wf-form4_152702254975642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000108/wf-form4_152702254975642.xml","form_type":"4"}},{"id":3945714,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-04T16:42:09.000Z","date":"2018-05-02","kind":"sale","acquired":false,"shares":1055,"price":6.18,"value":6519.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":703835,"source":{"system":"sec-edgar","filing":"0001487371-18-000088","document":"wf-form4_152546651633023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000088/wf-form4_152546651633023.xml","form_type":"4"}},{"id":4030856,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2018-02-27T19:43:08.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":110000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001487371-18-000054","document":"wf-form4_151977857378963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000054/wf-form4_151977857378963.xml","form_type":"4"}},{"id":4030855,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-27T19:43:08.000Z","date":"2018-02-26","kind":"sale","acquired":false,"shares":17300,"price":4.17,"value":72141.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":704890,"source":{"system":"sec-edgar","filing":"0001487371-18-000054","document":"wf-form4_151977857378963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000054/wf-form4_151977857378963.xml","form_type":"4"}},{"id":4030854,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-27T19:43:08.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":365000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. Of the amount reported, 35,000 restricted stock units vest in full (100%) on February 23, 2019. The remaining restricted stock units vest 25% on February 23, 2019 and in 12 equal quarterly installments thereafter."}],"balance_after":722190,"source":{"system":"sec-edgar","filing":"0001487371-18-000054","document":"wf-form4_151977857378963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000054/wf-form4_151977857378963.xml","form_type":"4"}},{"id":4044585,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-21T18:42:56.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":6584,"price":4.37,"value":28772.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":357190,"source":{"system":"sec-edgar","filing":"0001487371-18-000031","document":"wf-form4_151925656255256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000031/wf-form4_151925656255256.xml","form_type":"4"}},{"id":4073944,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-06T20:25:17.000Z","date":"2018-02-02","kind":"sale","acquired":false,"shares":1252,"price":5.13,"value":6422.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount reported includes 2,069 shares of the Issuer's common stock acquired under the GenMark Diagnostics, Inc. 2013 Employee Stock Purchase Plan since the reporting person last filed a Form 4 with the Securities Exchange Commission."}],"balance_after":363774,"source":{"system":"sec-edgar","filing":"0001487371-18-000021","document":"wf-form4_151796670318845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737118000021/wf-form4_151796670318845.xml","form_type":"4"}},{"id":4154689,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-21T18:04:48.000Z","date":"2017-11-20","kind":"sale","acquired":false,"shares":8252,"price":4.74,"value":39114.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":362957,"source":{"system":"sec-edgar","filing":"0001487371-17-000243","document":"wf-form4_151130547466796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000243/wf-form4_151130547466796.xml","form_type":"4"}},{"id":4173039,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-03T19:49:13.000Z","date":"2017-11-02","kind":"sale","acquired":false,"shares":1588,"price":7.24,"value":11497.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":371209,"source":{"system":"sec-edgar","filing":"0001487371-17-000224","document":"wf-form4_150975293964820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000224/wf-form4_150975293964820.xml","form_type":"4"}},{"id":4226729,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-23T14:37:06.000Z","date":"2017-08-21","kind":"sale","acquired":false,"shares":8311,"price":9.45,"value":78538.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":372797,"source":{"system":"sec-edgar","filing":"0001487371-17-000183","document":"wf-form4_150351341272987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000183/wf-form4_150351341272987.xml","form_type":"4"}},{"id":4242456,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-04T13:26:37.000Z","date":"2017-08-02","kind":"sale","acquired":false,"shares":1629,"price":10.33,"value":16827.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 1,374 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":381108,"source":{"system":"sec-edgar","filing":"0001487371-17-000168","document":"wf-form4_150186758352031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000168/wf-form4_150186758352031.xml","form_type":"4"}},{"id":4308463,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-23T16:51:46.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":8239,"price":12.89,"value":106200.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 7,400 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":384111,"source":{"system":"sec-edgar","filing":"0001487371-17-000113","document":"wf-form4_149557269089925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000113/wf-form4_149557269089925.xml","form_type":"4"}},{"id":4333508,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-04T17:10:39.000Z","date":"2017-05-02","kind":"sale","acquired":false,"shares":1571,"price":13.34,"value":20957.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 1,432 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":399750,"source":{"system":"sec-edgar","filing":"0001487371-17-000099","document":"wf-form4_149393222369127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000099/wf-form4_149393222369127.xml","form_type":"4"}},{"id":4392939,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-03-09T19:54:19.000Z","date":"2017-03-07","kind":"sale","acquired":false,"shares":1653,"price":12.18,"value":20133.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 1,472 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":402753,"source":{"system":"sec-edgar","filing":"0001487371-17-000077","document":"wf-form4_148910724626696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000077/wf-form4_148910724626696.xml","form_type":"4"}},{"id":4425020,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2017-02-24T19:20:09.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":63684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2017, December 31, 2018, and December 31, 2019; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2017, December 31, 2018, and December 31, 2019; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":63684,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":63684},"source":{"system":"sec-edgar","filing":"0001487371-17-000052","document":"wf-form4_148798199606161.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000052/wf-form4_148798199606161.xml","form_type":"4"}},{"id":4425019,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-24T19:20:09.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":191054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the reporting person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 25% on February 22, 2018 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter."}],"balance_after":405878,"source":{"system":"sec-edgar","filing":"0001487371-17-000052","document":"wf-form4_148798199606161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000052/wf-form4_148798199606161.xml","form_type":"4"}},{"id":4436489,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-21T20:02:03.000Z","date":"2017-02-21","kind":"sale","acquired":false,"shares":33537,"price":10.08,"value":338052.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 29,020 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":214824,"source":{"system":"sec-edgar","filing":"0001487371-17-000037","document":"wf-form4_148772530920339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000037/wf-form4_148772530920339.xml","form_type":"4"}},{"id":4468999,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-03T17:46:28.000Z","date":"2017-02-02","kind":"sale","acquired":false,"shares":1142,"price":11.58,"value":13224.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 1,861 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":277381,"source":{"system":"sec-edgar","filing":"0001487371-17-000023","document":"wf-form4_148616197567997.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000023/wf-form4_148616197567997.xml","form_type":"4"}},{"id":4485356,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2017-01-20T18:48:56.000Z","date":"2017-01-19","kind":"exercise","acquired":false,"shares":26649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The MSUs vest in three equal installments, on each of December 31, 2016, December 31, 2017, and December 31, 2018; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The MSUs vest in three equal installments, on each of December 31, 2016, December 31, 2017, and December 31, 2018; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":53299,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":26649},"source":{"system":"sec-edgar","filing":"0001487371-17-000012","document":"wf-form4_148495612345493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000012/wf-form4_148495612345493.xml","form_type":"4"}},{"id":4485355,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Market Stock Units","published_at":"2017-01-20T18:48:56.000Z","date":"2017-01-19","kind":"exercise","acquired":false,"shares":18116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."}],"balance_after":28468,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":18116},"source":{"system":"sec-edgar","filing":"0001487371-17-000012","document":"wf-form4_148495612345493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000012/wf-form4_148495612345493.xml","form_type":"4"}},{"id":4485354,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-20T18:48:56.000Z","date":"2017-01-19","kind":"sale","acquired":false,"shares":27124,"price":12.47,"value":338236.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted MSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person transferred 42,859 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable MSU vesting event."}],"balance_after":280384,"source":{"system":"sec-edgar","filing":"0001487371-17-000012","document":"wf-form4_148495612345493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000012/wf-form4_148495612345493.xml","form_type":"4"}},{"id":4485353,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-20T18:48:56.000Z","date":"2017-01-19","kind":"exercise","acquired":true,"shares":51867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Based on actual achievement for the one-year performance period, the recipient was issued 194.6% of the market stock units (\"MSUs\") which vested as of December 31, 2016."}],"balance_after":350367,"source":{"system":"sec-edgar","filing":"0001487371-17-000012","document":"wf-form4_148495612345493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000012/wf-form4_148495612345493.xml","form_type":"4"}},{"id":4485352,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-20T18:48:56.000Z","date":"2017-01-19","kind":"exercise","acquired":true,"shares":18116,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":298500,"source":{"system":"sec-edgar","filing":"0001487371-17-000012","document":"wf-form4_148495612345493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737117000012/wf-form4_148495612345493.xml","form_type":"4"}},{"id":4527171,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-09T18:00:24.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":1196,"price":11.08,"value":13251.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 1,929 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":280384,"source":{"system":"sec-edgar","filing":"0001487371-16-000401","document":"wf-form4_148132441172924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737116000401/wf-form4_148132441172924.xml","form_type":"4"}},{"id":4566761,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-11-04T17:36:58.000Z","date":"2016-11-02","kind":"sale","acquired":false,"shares":1148,"price":10.3,"value":11824.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 1,855 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":283509,"source":{"system":"sec-edgar","filing":"0001487371-16-000373","document":"wf-form4_147829540555991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737116000373/wf-form4_147829540555991.xml","form_type":"4"}},{"id":4606847,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":70087,"kind":"person","name":"MASSARANY HANY","position":1,"cik":"0001134554","reported_name":"MASSARANY HANY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-09T18:35:50.000Z","date":"2016-09-07","kind":"sale","acquired":false,"shares":1186,"price":8.69,"value":10306.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 1,939 shares of the Issuer's common stock into the Massarany Family Trust dated November 15, 2012 in connection with the applicable restricted stock units vesting event."}],"balance_after":286512,"source":{"system":"sec-edgar","filing":"0001487371-16-000355","document":"wf-form4_147346053794152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134554/000148737116000355/wf-form4_147346053794152.xml","form_type":"4"}}]}